XML 196 R49.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Details)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
Feb. 26, 2025
USD ($)
Jan. 09, 2025
USD ($)
Feb. 09, 2023
$ / shares
Summary of Significant Accounting Policies (Details) [Line Items]              
Impairment of equity method investment     $ 454,679      
Equity method investment   10,636,544 12,095,020      
Exceed federally-insured limits 250,000   250,000        
Federally insured limits $ 840,000   2,413,000        
Deferred offering costs     175,136      
Deferred rental income     38,346 11,429      
Advertising and marketing costs     $ 237,671 $ 1,666,721      
Common stock, conversion price (in Dollars per share) | $ / shares $ 11.25   $ 11.25 $ 22.5      
Percentage of purchase         40.00%   40.00%
Reverse stock split 1-for-15   1-for-15 1:10      
Carrying value equity method investment $ 95,000          
Redemption aggregate cash amount 1,745,000            
Payment of equity investment 95,000            
Regular payments on equity investments 75,000            
Receivable from sale of equity method investment 1,650,000            
Current assets 2,794,258   $ 3,236,498 $ 850,867      
Non-current assets 7,815,531   $ 17,748,680 19,731,669      
Dilutive securities $ 162,473            
Pre-Funded Warrants [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Warrants outstanding (in Shares) | shares 150,000   150,000        
Epicon Biotech Co., Ltd [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Impairment of equity method investment       454,679      
Equity method investment       $ 0      
Dr. Yu Zhou [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equity interest percent     40.00%        
Common Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Common stock, conversion price (in Dollars per share) | $ / shares       $ 67.5      
Research and Development Expense [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Research and development expense     $ 0 $ 109,618      
Business Combination [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Asset acquisition percentage     40.00%        
Equity Method Investment [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Impairment charges     $ 259,579 9,651,361      
Lab Services MSO [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equity interest percent 40.00%            
Carrying value equity method investment $ 11,000,000            
Redemption aggregate cash amount 11,029,221            
Carrying value of the extinguished 632,916            
Current assets 975,000            
Non-current assets 675,000            
Lab Services MSO [Member] | Pre-Funded Warrants [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Carrying value equity method investment $ 13,377,916            
Laboratory Services MSO, LLC [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equity method investment     259,579 $ 9,196,682      
Laboratory Equipment [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Impairment of equity method investment     $ 111,033        
RMB [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Foreign currency exchange rate     7.1889 7.0752      
RMB [Member] | Asset and liability Accounts [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Foreign currency exchange rate     7.298 7.0786      
United States [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Foreign currency exchange rate       1      
United States [Member] | Asset and liability Accounts [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Foreign currency exchange rate       1      
Deferred Offering Costs [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Deferred offering costs     $ 0        
Series A Convertible Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares     $ 150        
Series B Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equity method investment         $ 11,000,000    
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares $ 56.7   56.7       $ 56.7
Common stock, conversion price (in Dollars per share) | $ / shares $ 56.7   56.7        
Carrying value of the extinguished $ 2,348,695            
Series B Preferred Stock [Member] | Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares $ 22.5            
Series B Preferred Stock [Member] | Lab Services MSO [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equity method investment $ 11,000,000            
Series C Convertible Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares $ 2.41   2.41        
Series C Convertible Preferred Stock [Member] | Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares 15   2.41        
Series A Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares 150   150        
Series A Preferred Stock [Member] | Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares 67.5            
Series D Convertible Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Equity method investment           $ 9,000,000  
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares 2.41   $ 2.41        
Series D Convertible Preferred Stock [Member] | Preferred Stock [Member]              
Summary of Significant Accounting Policies (Details) [Line Items]              
Preferred stock, convertible conversion price (in Dollars per share) | $ / shares $ 2.41